Nov 12, 2020 Roth Capital Partners acted as Sole Placement Agent for a $6.9 Million Secondary Registered Direct: Lung Therapeutics sold shares of TFF Pharmaceuticals Roth Capital Partners
Nov 12, 2020 Roth Capital Partners acted as Sole Book-Running Manager for InMed Pharmaceuticals Inc. (NASDAQ: INM) in its US$8 Million Follow-On Roth Capital Partners
Nov 10, 2020 Roth Capital Partners to Host Technology Virtual Event November 11-12, 2020 Business Wire
Nov 9, 2020 ROTH Capital Partners Acts as Sole Book-Running Manager for Reed's Inc. (Nasdaq: REED) in its $12.1 Million Follow-On Roth Capital Partners
Oct 26, 2020 Roth Capital Partners acts as Co-Manager for Turning Point Therapeutics, Inc. (Nasdaq: TPTX) in its $460 Million Follow-On Roth Capital Partners
Oct 22, 2020 Roth Capital Partners acts as Co-Manager for Replimune Group, Inc. (Nasdaq: REPL) in its $287.5 Million Follow-On Roth Capital Partners
Oct 22, 2020 Roth Capital Partners announces the addition of Hershel Gerson, Managing Director, Co-Head of Consumer Investment Banking Roth Capital Partners
Oct 20, 2020 Roth Capital Partners acts as Financial Advisor for ThinkIQ in its $11.6 Million Series A Financing Roth Capital Partners
Oct 19, 2020 Roth Capital Partners, NGO Sustainability with the Governments of Portugal, Kenya, and Sri Lanka Hosted a Virtual Side Event Business Wire